Skip to main content

Post-IPO Debt Biotechnology Companies

Explore 90 biotechnology startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
90
Total Funding
$5.5B
Avg Funding
$221.3M
Cities
20

Export 90 Post-IPO Debt Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Newton, United States
$1.0M
raised

Acer Therapeutics focuses on the acquisition, development, and commercialization of therapies for patients with serious rare diseases.

Jun 2023
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New York, United States
$250.0M
raised

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$10.0M
raised

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Helsinki, Finland
$5.8M
raised

Nanoform is a pioneering company driven by a passion for innovation and a commitment to solving our partners’ problems.

Jun 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$11.8M
raised

Juva Life brings a depth of knowledge in the science and medicinal effects of cannabis.

Jun 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Chicago, United States
$400.0M
raised

Tempus develops AI-enabled precision medicine technology that supports clinical decision-making and biomedical research.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New Hope, United States
$35.0M
raised

Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New Haven, United States
$500K
raised

Precipio Diagnostics is a cancer diagnostics reference laboratory delivering advanced diagnostics, advice and personalized medicine.

May 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Irvine, United States
$150.0M
raised

Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.

May 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Malvern, United States
$115.0M
raised

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$1.3B
raised

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States
$50.0M
raised

Pioneering Potent, Safer Cell Therapy in and Beyond Oncology

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Brussels, Belgium
$1.4B
raised

Syensqo is a developer of chemical solvents for industries like aerospace, automotive, food, and agriculture and for the end user customers.

May 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Saskatoon, Canada
$505K
raised

ZYUS is a biopharmaceutical company that offers patients cannabinoid and other phyto-therapeutic medical solutions.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$10.0M
raised

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

New York, United States
$570.0M
raised

Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.

May 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Foster City, United States
$600.0M
raised

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

May 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$711K
raised

Magnasense will create technology for biomarker assays that are easily accessible.

Apr 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Calgary, Canada
$361K
raised

Marvel Biosciences is a life sciences company.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Newton, United States
$6.0M
raised

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Farmington Hills, United States
$35.0M
raised

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Apr 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$20.0M
raised

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Apr 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 90 companies

Ready to Connect with Post-IPO Debt Biotechnology Startups?

Get verified founder emails, funding details, and company data for 90 post-ipo debt biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

90 Biotechnology Post-IPO Debt Startups (September 2026) — Page 2 | VCBacked